Aziyo Biologics Inc. (AZYO) Prices 2.941M Share IPO at $17/Sh

Aziyo Biologics, Inc. (NASDAQ: AZYO) today announced the pricing of its initial public offering of 2,941,176 shares of common stock, consisting of 2,205,882 shares of Class A common stock and 735,294 shares of Class B common stock, each at a public offering price of $17.00 per share, before deducting underwriting discounts and commissions. All of the common stock is being offered by Aziyo. The offering is expected to close on October 13, 2020, subject to customary closing conditions. In addition, Aziyo has granted the underwriters a 30-day option to purchase up to an additional 441,176 shares of its Class A common stock at the initial public offering price less the underwriting discounts and commissions. The gross proceeds of the offering are expected to be $50.0 million, excluding any exercise of the underwriters’ option.

Aziyo’s Class A common stock is expected to begin trading on the Nasdaq Global Market on October 8, 2020, under the ticker symbol “AZYO.”

Piper Sandler and Cowen are acting as joint book-running managers for the offering. Cantor and Truist Securities are acting as co-managers for the offering.

You May Also Be Interested In

• Barrick Mining said to delay IPO of American gold business to 2027
• Helfie AI names John Rego as its new CFO
• Rainier Acquisition Corporation Announces Full Exercise of Over-Allotment Option, Bringing Total IPO Gross Proceeds to $86,250,000